• Sagimet Biosciences set an inducement equity award covering 34,300 stock options for two newly hired employees.
• Options were granted June 22, 2026 to buy Series A common stock at the June 22 Nasdaq closing price.
• Awards carry a 10-year term; 25% vests after one year, with the balance vesting monthly over the next 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sagimet Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606222049PRIMZONEFULLFEED9750867) on June 23, 2026, and is solely responsible for the information contained therein.